Mass Spectrometric Screening for Improving Enzymatic Conversion of Formaldehyde into C2 and C3 Products
ACS Synthetic Biology · 2025
DOI: 10.1021/acssynbio.5c00151 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Synthetic Biology, 2025. Verfasst von Yizhou Luo und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese …. Hauptthemen laut MEDLINE: Formaldehyde, Mass Spectrometry, Aldehyde Oxidoreductases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Science and Technology Planning Project of Guangdong Province, National Key Research and Development Program of China, Shenzhen Science and Technology Innovation Program.
Abstract (Originalsprache)
One-carbon biomanufacturing offers a sustainable route for producing value-added chemicals. Glycolaldehyde synthase (GALS), an engineered enzyme from Pseudomonas putida, catalyzes a key step by condensing formaldehyde (FALD) into carbohydrate molecules, such as glycolaldehyde (GALD) and dihydroxyacetone (DHA). However, its industrial application is limited by low catalytic efficiency and lack of high-throughput screening methods. Here, we developed a mass spectrometry (MS)-based assay for simultaneous detection and quantification of GALD and DHA products from whole-cell FALD biotransformation by GALS-expressing Escherichia coli. Integrating this MS assay with a robotic biofoundry, we created and screened site-directed mutagenesis libraries targeting seven key residues of GALS, achieving a throughput of ∼10 s per sample. Several improved mutants were successfully isolated, including one with a 3.7-fold increase in kcat for GALD production and another with a 5-fold reduction in Km for DHA production, compared to the wild type GALS. Molecular dynamics simulations were applied to understand the mutational impact on substrate binding and product specificity. This high-throughput workflow may be extended to engineer other enzymes for one-carbon feedstock utilization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- School of Life Sciences, Henan University, Kaifeng 475004, China.
- Shenzhen Research Institute of Henan University, Shenzhen 518000, China.
ORCID-Profile: Tong Si
Förderung
- Science and Technology Planning Project of Guangdong Province
- National Key Research and Development Program of China
- Shenzhen Science and Technology Innovation Program
- Chinese Academy of Sciences
Zitieren
APA
Luo, Y., Fu, L., Chen, J., Xu, H., Song, Z., Jalal, K., Chen, Y., Xie, W., Tian, S., Fang, X., Si, T., & Zhang, J. (2025). Mass Spectrometric Screening for Improving Enzymatic Conversion of Formaldehyde into C2 and C3 Products. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.5c00151
Vancouver
Luo Y, Fu L, Chen J, Xu H, Song Z, Jalal K, et al. Mass Spectrometric Screening for Improving Enzymatic Conversion of Formaldehyde into C2 and C3 Products. ACS Synthetic Biology. 2025. doi:10.1021/acssynbio.5c00151
BibTeX
@article{Luo2025,
author = {Luo, Yizhou and Fu, Lihao and Chen, Jueru and Xu, Hongrong and Song, Zeqi and Jalal, Khurshid and Chen, Yongcan and Xie, Wenhao and Tian, Shujun and Fang, Xiaoting and Si, Tong and Zhang, Jianzhi},
title = {Mass Spectrometric Screening for Improving Enzymatic Conversion of Formaldehyde into C2 and C3 Products},
journal = {ACS Synthetic Biology},
year = {2025},
doi = {10.1021/acssynbio.5c00151}
}
EUVIMED